NCT01489696View on ClinicalTrials.gov

A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
CardiovascularHealthy SubjectsPharmacokinetics
Interventions
DRUG

mirabegron

oral

DRUG

tamsulosin

oral

Trial Locations (1)

LS2 9LH

Covance CRU Ltd, Leeds

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01489696 - A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin | Biotech Hunter | Biotech Hunter